- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/64 - General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
Patent holdings for IPC class C12N 15/64
Total number of patents in this class: 1143
10-year publication summary
|
56
|
60
|
60
|
74
|
92
|
60
|
65
|
84
|
70
|
63
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4296 |
22 |
| Shenzhen Biocan Technologies Co., Ltd. | 147 |
22 |
| Aldevron, L.L.C. | 87 |
18 |
| Generation Bio Co. | 145 |
16 |
| President and Fellows of Harvard College | 5993 |
14 |
| The Regents of the University of California | 19989 |
11 |
| The Johns Hopkins University | 5679 |
11 |
| Massachusetts Institute of Technology | 10066 |
9 |
| The Trustees of the University of Pennsylvania | 4326 |
8 |
| Orna Therapeutics, Inc. | 56 |
8 |
| Telesis Bio Inc. | 61 |
8 |
| DSM IP Assets B.V. | 5589 |
7 |
| Life Technologies Corporation | 3311 |
7 |
| Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences | 2037 |
7 |
| BASF SE | 20945 |
6 |
| Lifeedit Therapeutics, Inc. | 57 |
6 |
| Novartis AG | 10741 |
5 |
| F. Hoffmann-La Roche AG | 7945 |
5 |
| Genentech, Inc. | 3978 |
5 |
| Centre National de La Recherche Scientifique | 10465 |
5 |
| Other owners | 943 |